Vibhavadi Medical Center PCL (BKK:VIBHA-R) 1-Year Sharpe Ratio: -1.08 (As of Jul. 12, 2026)


BKK:VIBHA-R Vibhavadi Medical Center PCL BKK:VIBHA-R
70 GF Score
Price ฿1.36
GF Value ฿1.65
! 5 Warning Signs
View Full Analysis

What is Vibhavadi Medical Center PCL 1-Year Sharpe Ratio?

Vibhavadi Medical Center PCL BKK:VIBHA-R 70 1-Year Sharpe Ratio is -1.08 as of Jul. 12, 2026. GuruFocus rates BKK:VIBHA-R with a GF Score™ of 70/100 and a GF Value™ of ฿1.65. The stock has 5 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-12), Vibhavadi Medical Center PCL's 1-Year Sharpe Ratio is -1.08.


Vibhavadi Medical Center PCL  (BKK:VIBHA-R) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Vibhavadi Medical Center PCL 1-Year Sharpe Ratio Related Terms


BKK:VIBHA-R vs HCA, THC, DVA: 1-Year Sharpe Ratio Comparison

For the Medical Care Facilities subindustry, Vibhavadi Medical Center PCL's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vibhavadi Medical Center PCL 1-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vibhavadi Medical Center PCL's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Vibhavadi Medical Center PCL's 1-Year Sharpe Ratio falls into.


BKK:VIBHA-R
70GF Score
Vibhavadi Medical Center PCL BKK:VIBHA-R
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vibhavadi Medical Center PCL 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -1.08 mean?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a 1-Year Sharpe Ratio of -1.08 as of Jul. 12, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Vibhavadi Medical Center PCL and its competitors.
Is Vibhavadi Medical Center PCL's 1-Year Sharpe Ratio too high?
Vibhavadi Medical Center PCL's current 1-Year Sharpe Ratio is -1.08. Overall, Vibhavadi Medical Center PCL has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Vibhavadi Medical Center PCL's 1-Year Sharpe Ratio compare to HCA and THC?
Vibhavadi Medical Center PCL's 1-Year Sharpe Ratio of -1.08 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Healthcare Providers & Services company?
A good 1-Year Sharpe Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Vibhavadi Medical Center PCL and its competitors. Vibhavadi Medical Center PCL's current 1-Year Sharpe Ratio is -1.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibhavadi Medical Center PCL stock overvalued right now?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a current 1-Year Sharpe Ratio of -1.08. The stock's GF Value™ is ฿1.65, compared to a current price of ฿1.36 — trading 17.6% below its estimated fair value. The current 1-Year Sharpe Ratio is -1.08. Vibhavadi Medical Center PCL's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Vibhavadi Medical Center PCL (BKK:VIBHA-R), the current 1-Year Sharpe Ratio is -1.08 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vibhavadi Medical Center PCL (BKK:VIBHA-R) Overvalued in 2026?

Based on GuruFocus' analysis, Vibhavadi Medical Center PCL stock appears to be undervalued. The current stock price of ฿1.36 is trading 17.6% below its estimated GF Value™ of ฿1.65.

Key valuation signals for BKK:VIBHA-R:

  • 1-Year Sharpe Ratio: -1.08
  • GF Value™: ฿1.65 vs. price of ฿1.36 (17.6% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the BKK:VIBHA-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vibhavadi Medical Center PCL Business Description

Other Exchanges VIBHA:Thailand
Address 51/3 Ngam Wong Wan Road, Latyao Sub-District, Chatuchak District, Bangkok, THA, 10900
Vibhavadi Medical Center PCL provides the medical services known as Vibhavadi Hospital. The services provided include Pediatric Diseases, General Surgery, Orthopedic Center, General Medicine, Women's Health, Gastrointestinal Center, Cardiology, Neurology, Brain Tumor Surgery, Gamma Knife Radiosurgery for Brain, Cancer, Respiratory Diseases, Plastic Surgery, ENT (Ear, Nose, Throat) Department, Dental Center, Life Style Health Screening Center, Lasik Center, Eye, Hemodialysis Department, Dermatology Center, and Other Clinics and Services. Its segments include Hospital provides general hospital and hospital in social security; and Others provide rental services and rental space. The majority of the revenue is derived from the Hospital segment.
70GF Score

Get the complete analysis for BKK:VIBHA-R

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.36
Price
฿1.65
GF Value